Guardant Health
GH
#1509
Rank
A$20.75 B
Marketcap
A$159.77
Share price
3.69%
Change (1 day)
181.15%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -A$0.63 Billion

According to Guardant Health 's latest financial reports the company's current earnings are A$0.90 Billion. In 2024 the company made an earning of -A$0.66 Billion, an increase over its 2023 earnings that were of -A$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.63 Billion-5.47%
2024 -A$0.66 Billion-9.12%
2023 -A$0.73 Billion-26.73%
2022 -A$0.99 Billion69.96%
2021 -A$0.59 Billion56.35%
2020 -A$0.38 Billion252.69%
2019 -A$0.11 Billion-17.22%
2018 -A$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Natera
NTRA
-A$0.47 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-A$1.63 Billion 170.04%๐Ÿ‡บ๐Ÿ‡ธ USA